(Q41653529)

6 October 2017

1 reference

title

Hypertension and pathologic cardiovascular remodeling: a potential therapeutic role for T-type calcium antagonists (English)

1 reference

6 October 2017

Giles TD

1

1 reference

6 October 2017

publication date

1 January 1997

1 reference

6 October 2017

published in

Clinical Therapeutics

1 reference

6 October 2017

volume

19 Suppl A

1 reference

6 October 2017

page(s)

27-38

1 reference

Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension.

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Cardiac hypertrophy. Mechanical, neural, and endocrine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Heart failure from the point of view of quantitative anatomy∗

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Clinical and morphological features of human hypertensive-diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Myocardial disease in hypertensive-diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Structure and function of small arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Exacerbation of atherosclerosis by hypertension. Potential mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Effects of protection from pressure on resistance artery morphology and reactivity in spontaneously hypertensive and Wistar-Kyoto rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Physiological aspects of primary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Small artery structure in hypertension. Dual processes of remodeling and growth

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

The pathogenesis of atherosclerosis--an update

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Ventricular function and coronary hemodynamics in hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Rapid ventricular filling in left ventricular hypertrophy: II. Pathologic hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Impaired left ventricular functional reserve in hypertensive patients with left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Unrecognized myocardial infarction and hypertension: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Heterogeneity of the atherosclerotic process in systemic hypertension poorly controlled by drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Regression of cardiovascular structural changes--a preventive strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both alpha 1- and beta-adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Role of hypertension in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial: PROTECT

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Regression of media-to-lumen ratio of human subcutaneous arteries and left ventricular hypertrophy during treatment with an angiotensin-converting enzyme inhibitor-based regimen in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Antiatherogenic properties of calcium antagonists. State of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Receptor sites for Ca2+ channel antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Endothelin-1 enhances calcium entry through T-type calcium channels in cultured neonatal rat ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

T-type Ca2+ current is expressed in hypertrophied adult feline left ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

T-type Ca2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Voltage‐dependent calcium entry in confluent bovine capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Differential expression of voltage-gated Ca(2+)-currents in cultivated aortic myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

T-type calcium channels in adrenal glomerulosa cells: GTP-dependent modulation by angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

The angiotensin AT2 receptor modulates T-type calcium current in non-differentiated NG108-15 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Ca2+ influx via T-type channels modulates PDGF-induced replication of mouse fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Antihypertensive properties of the novel calcium antagonist mibefradil (Ro 40-5967): a new generation of calcium antagonists? Mibefradil International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Effects of a new calcium antagonist, mibefradil (Ro 40-5967), on silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The Mibefradil International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Selective inhibition of T-type Ca2+ channels by Ro 40-5967

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Modulation of [3H]dihydropyridine binding by activation of protein kinase C in vascular smooth muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

The design of the Mortality Assessment in Congestive Heart Failure Trial (MACH-1, mibefradil).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980035-5

7 January 2021

10.1016/S0149-2918(97)80035-5

Identifiers

DOI

1 reference

6 October 2017

1 reference